|
Diabetes, Vol 46, Issue 10 1619-1626, Copyright © 1997 by American Diabetes Association
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I
RS Punglia, M Lu, J Hsu, M Kuroki, MJ Tolentino, K Keough, AP Levy, NS Levy, MA Goldberg, RJ D'Amato and AP Adamis
Laboratory for Surgical Research, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Insulin-like growth factor I (IGF-I) and vascular endothelial growth factor
(VEGF) levels are correlated with retinal ischemia-associated intraocular
neovascularization in humans. Since VEGF is required for iris and retinal
neovascularization in animal models of retinal ischemia, we tested whether
IGF-I could act as an indirect angiogenic factor by increasing VEGF gene
expression. IGF-I increased retinal pigment epithelial (RPE) cell VEGF mRNA
in a concentration-dependent manner with an EC50 of 7 nmol/1 (53.6 ng/ml).
RPE and bovine smooth muscle cells exposed to 50 nmol/l (383 ng/m1) IGF-I
achieved peak VEGF mRNA expression within 2 h. IGF-I-treated RPE cells
increased VEGF protein levels in conditioned media and stimulated capillary
endothelial cell proliferation. Blockade of the IGF-I receptor with a
neutralizing antibody abrogated the VEGF increases in RPE cells. Further,
hypoxia-mediated and IGF-I-mediated increases in VEGF mRNA and protein
levels were additive in RPE cells, and the hypoxia-induced VEGF increases
were independent of endogenous IGF-I. VEGF promoter activity was enhanced
by IGF-I in RPE cells, but VEGF transcript half-life was unaltered. In
summary, the supplementation of RPE and smooth muscle cell cultures with
IGF-I at 5-100 nmol/l increased VEGF mRNA and secreted protein levels. The
VEGF increases in RPE cells occurred primarily through enhanced
transcription of the VEGF gene and via the IGF-I receptor. Elevated IGF-I
levels may promote neovascularization through increased retinal VEGF gene
expression.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Yang, J. Amir, H. Liu, and B. Chaqour
Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis
Physiol Genomics,
December 1, 2008;
36(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Economou, J. Wu, D. Vasilcanu, L. Rosengren, C. All-Ericsson, I. van der Ploeg, E. Menu, L. Girnita, M. Axelson, O. Larsson, et al.
Inhibition of VEGF Secretion and Experimental Choroidal Neovascularization by Picropodophyllin (PPP), an Inhibitor of the Insulin-like Growth Factor-1 Receptor
Invest. Ophthalmol. Vis. Sci.,
June 1, 2008;
49(6):
2620 - 2626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Paisley, C. J. O'Callaghan, K. C. Lewandowski, C. Parkinson, M. E. Roberts, W. M. Drake, J. P. Monson, P. J. Trainer, and H. S. Randeva
Reductions of Circulating Matrix Metalloproteinase 2 and Vascular Endothelial Growth Factor Levels after Treatment with Pegvisomant in Subjects with Acromegaly
J. Clin. Endocrinol. Metab.,
November 1, 2006;
91(11):
4635 - 4640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Slomiany and S. A. Rosenzweig
Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion
J. Pharmacol. Exp. Ther.,
August 1, 2006;
318(2):
666 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. A. Beharry, H. D. Modanlou, J. Hasan, Z. Gharraee, P. Abad-Santos, J. H. Sills, A. Jan, S. Nageotte, and J. V. Aranda
Comparative Effects of Early Postnatal Ibuprofen and Indomethacin on VEGF, IGF-I, and GH during Rat Ocular Development.
Invest. Ophthalmol. Vis. Sci.,
July 1, 2006;
47(7):
3036 - 3043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, M.-N. Monthouel-Kartmann, and E. Van Obberghen
Regulation of Hypoxia-Inducible Factor (HIF)-1 Activity and Expression of HIF Hydroxylases in Response to Insulin-Like Growth Factor I
Mol. Endocrinol.,
May 1, 2005;
19(5):
1304 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. X. Zhang, J.-x. Ma, J. Sima, Y. Chen, M. S. Hu, A. Ottlecz, and G. N. Lambrou
Genetic Difference in Susceptibility to the Blood-Retina Barrier Breakdown in Diabetes and Oxygen-Induced Retinopathy
Am. J. Pathol.,
January 1, 2005;
166(1):
313 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Slomiany and S. A. Rosenzweig
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19
Am J Physiol Cell Physiol,
September 1, 2004;
287(3):
C746 - C753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Slomiany and S. A. Rosenzweig
IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407
Invest. Ophthalmol. Vis. Sci.,
August 1, 2004;
45(8):
2838 - 2847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Poulaki, A. M. Joussen, N. Mitsiades, C. S. Mitsiades, E. F. Iliaki, and A. P. Adamis
Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy
Am. J. Pathol.,
August 1, 2004;
165(2):
457 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lopez-Lopez, D. LeRoith, and I. Torres-Aleman
Insulin-like growth factor I is required for vessel remodeling in the adult brain
PNAS,
June 29, 2004;
101(26):
9833 - 9838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Murdaca, C. Treins, M.-N. Monthouel-Kartmann, R. Pontier-Bres, S. Kumar, E. Van Obberghen, and S. Giorgetti-Peraldi
Grb10 Prevents Nedd4-mediated Vascular Endothelial Growth Factor Receptor-2 Degradation
J. Biol. Chem.,
June 18, 2004;
279(25):
26754 - 26761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Randeva, K. C. Lewandowski, J. Komorowski, R. D. Murray, C. J. O'Callaghan, E. W. Hillhouse, H. Stepien, and S. M. Shalet
Growth Hormone Replacement Decreases Plasma Levels of Matrix Metalloproteinases (2 and 9) and Vascular Endothelial Growth Factor in Growth Hormone-Deficient Individuals
Circulation,
May 25, 2004;
109(20):
2405 - 2410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay
Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells
J. Biol. Chem.,
February 6, 2004;
279(6):
3941 - 3948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev.,
October 1, 2003;
24(5):
600 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Shaw, A. Afzal, A. S. Lewin, A. M. Timmers, P. E. Spoerri, and M. B. Grant
Decreased Expression of the Insulin-like Growth Factor 1 Receptor by Ribozyme Cleavage
Invest. Ophthalmol. Vis. Sci.,
September 1, 2003;
44(9):
4105 - 4113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Lambooij, K. H. M. van Wely, D. J. Lindenbergh-Kortleve, R. W. A. M. Kuijpers, M. Kliffen, and C. M. Mooy
Insulin-like Growth Factor-I and its Receptor in Neovascular Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci.,
May 1, 2003;
44(5):
2192 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Franklin, R. J. Ferry Jr., and P. Cohen
Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
900 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. N. Han, M. Post, A. K. Tanswell, and S. J. Lye
Insulin-Like Growth Factor-I Receptor-Mediated Vasculogenesis/Angiogenesis in Human Lung Development
Am. J. Respir. Cell Mol. Biol.,
February 1, 2003;
28(2):
159 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Burroughs, J. Oh, J. C. Barrett, and R. P. DiAugustine
Phosphatidylinositol 3-Kinase and Mek1/2 Are Necessary for Insulin-Like Growth Factor-I-Induced Vascular Endothelial Growth Factor Synthesis in Prostate Epithelial Cells: A Role for Hypoxia-Inducible Factor-1?
Mol. Cancer Res.,
February 1, 2003;
1(4):
312 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, and E. Van Obberghen
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
J. Biol. Chem.,
July 26, 2002;
277(31):
27975 - 27981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Derevjanik, S. A. Vinores, W.-H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro
Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice
Invest. Ophthalmol. Vis. Sci.,
July 1, 2002;
43(7):
2462 - 2467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Ritter, M. I. Dorrell, J. Edmonds, S. F. Friedlander, and M. Friedlander
From the Cover: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis
PNAS,
May 28, 2002;
99(11):
7455 - 7460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gao, Y. Li, S. Gee, A. Dudley, J. Fant, C. Crosson, and J.-x. Ma
Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor. A POSSIBLE MECHANISM FOR THE ANTI-ANGIOGENIC ACTIVITY OF PLASMINOGEN KRINGLE 5
J. Biol. Chem.,
March 8, 2002;
277(11):
9492 - 9497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
J. Biol. Chem.,
November 16, 2001;
276(47):
43836 - 43841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hangai, T. Murata, N. Miyawaki, C. Spee, J. I. Lim, S. He, D. R. Hinton, and S. J. Ryan
Angiopoietin-1 Upregulation by Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
June 1, 2001;
42(7):
1617 - 1625.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Wellmann, T. Taube, K. Paal, H. Graf v. Einsiedel, W. Geilen, G. Seifert, C. Eckert, G. Henze, and K. Seeger
Specific Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor (VEGF) Splice Variants by LightCycler Technology
Clin. Chem.,
April 1, 2001;
47(4):
654 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schwesinger, C. Yee, R. M. Rohan, A. M. Joussen, A. Fernandez, T. N. Meyer, V. Poulaki, J. J. K. Ma, T. M. Redmond, S. Liu, et al.
Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium
Am. J. Pathol.,
March 1, 2001;
158(3):
1161 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Talks, H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, and A. L. Harris
The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1{alpha} and HIF-2{alpha} in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages
Am. J. Pathol.,
August 1, 2000;
157(2):
411 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dahlfors and H. J. Arnqvist
Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 Regulate the Expression of Insulin-Like Growth Factor-Binding Protein-3, -4, and -5 in Large Vessel Endothelial Cells
Endocrinology,
June 1, 2000;
141(6):
2062 - 2067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fournier and M. I. Lewis
Influences of IGF-I gene disruption on the cellular profile of the diaphragm
Am J Physiol Endocrinol Metab,
April 1, 2000;
278(4):
E707 - E715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lu, S. Amano, K. Miyamoto, R. Garland, K. Keough, W. Qin, and A. P. Adamis
Insulin-Induced Vascular Endothelial Growth Factor Expression in Retina
Invest. Ophthalmol. Vis. Sci.,
December 1, 1999;
40(13):
3281 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kim, A. M. Ryan, R. Rohan, S. Amano, S. Agular, J. W. Miller, and A. P. Adamis
Constitutive Expression of VEGF, VEGFR-1, and VEGFR-2 in Normal Eyes
Invest. Ophthalmol. Vis. Sci.,
August 1, 1999;
40(9):
2115 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hirano, M. B. S. Lopes, E. R. Laws Jr., T. Asakura, M. Goto, J. E. Carpenter, L. R. Karns, and S. R. VandenBerg
Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas
Neuro-oncol,
April 1, 1999;
1(2):
109 - 119.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R.L. Gardner, S. Squire, S. Zaina, S. Hills, and C.F. Graham
Insulin-Like Growth Factor-2 Regulation of Conceptus Composition: Effects of the Trophectoderm and Inner Cell Mass Genotypes in the Mouse
Biol Reprod,
January 1, 1999;
60(1):
190 - 195.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. C. Levine, X.-H. Liu, P. D. Greenberg, M. Eliashvili, J. D. Schiff, S. A. Aaronson, J. F. Holland, and A. Kirschenbaum
Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts
Endocrinology,
November 1, 1998;
139(11):
4672 - 4678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Neely and T. W. Gardner
Ocular Neovascularization : Clarifying Complex Interactions
Am. J. Pathol.,
September 1, 1998;
153(3):
665 - 670.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M KNOTT
Insulin-like growth factor type 1---friend or foe?
Br. J. Ophthalmol.,
July 1, 1998;
82(7):
719 - 720.
[Full Text]
|
 |
|

|
 |

|
 |
 
E Chantelau
Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
Br. J. Ophthalmol.,
July 1, 1998;
82(7):
725 - 730.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Miele, J. J. Rochford, N. Filippa, S. Giorgetti-Peraldi, and E. Van Obberghen
Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways
J. Biol. Chem.,
July 7, 2000;
275(28):
21695 - 21702.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|